John Williams Archives
Natural killer cells don’t clear HMPV
Jul. 23, 2014—Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments.
Study identifies antibody that may fight MPV, RSV
Jul. 17, 2014—New Vanderbilt-led research published in the Journal of Infectious Diseases has identified an antibody that shows promise in preventing and treating human metapneumovirus (MPV) and respiratory syncytial virus (RSV) — the two leading causes of respiratory infections in young children.
Respiratory virus vaccine candidate
May. 27, 2014—Virus-like particles containing a protein from human metapneumovirus are a promising vaccine candidate for this respiratory virus.
Research reveals clues to childhood respiratory virus
Feb. 14, 2013—New Vanderbilt-led research published in the Feb. 14 issue of the New England Journal of Medicine has identified the relatively unknown human metapneumovirus (MPV) as the second most common cause of severe bronchiolitis in young children.
Cell entry ports for cold virus
Sep. 25, 2012—The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.
New therapeutic target for cold, flu viruses identified
Aug. 9, 2012—Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.
Researchers spot Achilles’ heel in respiratory virus
Apr. 13, 2012—A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.
